Group 1 - The company's operating revenue for 2024 is 5.677 billion yuan, a year-on-year decrease of 11.88% [1] - The net profit attributable to shareholders of the listed company is 103 million yuan, a year-on-year increase of 122.17% [1] - The basic earnings per share is 0.1118 yuan per share [1] Group 2 - The company plans to distribute a cash dividend of 0.2 yuan (including tax) for every 10 shares to all shareholders [1] - No bonus shares will be issued, and there will be no capital reserve fund conversion to increase share capital [1]

Core Viewpoint - Lianhua Technology's stock closed at 6.24 yuan, with a market capitalization of 5.687 billion yuan, and the company has shown a significant increase in net profit despite a decline in revenue [1] Group 1: Company Overview - Lianhua Technology specializes in fine chemicals and engineering services, with key segments including crop protection, pharmaceuticals, and functional chemicals [1] - The company has established itself as a strategic supplier for major international agricultural and pharmaceutical companies, being recognized as a key high-tech enterprise under the National Torch Program [1] Group 2: Financial Performance - For the third quarter of 2024, Lianhua Technology reported revenue of 4.359 billion yuan, a year-on-year decrease of 13.14%, while net profit reached 32.5038 million yuan, reflecting a year-on-year increase of 143.13% [1] - The company's gross profit margin stood at 22.71% [1] Group 3: Market Position - As of the third quarter of 2024, 129 institutions hold shares in Lianhua Technology, with a total holding of 32.6383 million shares valued at 180 million yuan [1] - The company's price-to-earnings ratio (TTM) is -15.91, and its price-to-book ratio is 0.89, indicating a lower valuation compared to industry averages [2]

Investment Rating - The industry investment rating is "Recommended" (maintained) [1] Core Viewpoints - The chemical industry is expected to enter a replenishment cycle in 2025 due to several factors, including decreasing inventory levels, bottoming out of profits, and institutional holdings reaching a low point [8][30] - The supply-demand tension in phosphate rock is likely to continue, with a potential revaluation of its value, particularly focusing on the capacity expansion of Batian Co., Ltd [4][6] - The impact of the new round of tariffs imposed by the U.S. on Chinese chemical enterprises is expected to be limited, as the U.S. still needs to import a significant amount of chemical products from China [4] Summary by Sections Market Performance - The basic chemical sector showed a performance of 0.0% over the last month, 8.4% over the last three months, and 1.2% over the last year, compared to the CSI 300 index which had performances of -0.7%, 2.3%, and 8.2% respectively [2] Investment Suggestions - Focus on companies with low-cost expansion opportunities, such as Wanhu Chemical, and those in the tire and fertilizer sectors [8] - Highlight the potential for increased demand in phosphate fertilizers and lithium iron phosphate batteries, with ongoing projects in fine phosphate chemicals [4][6] - Emphasize high dividend yield opportunities in state-owned enterprises within the chemical sector, including China Petroleum and China National Offshore Oil Corporation [10] Key Company Tracking - Batian Co., Ltd. plans to expand its phosphate rock production capacity from 900,000 tons/year to 2 million tons/year, with additional projects underway [6] - The chemical industry is expected to benefit from rising prices in sulfuric acid, acrylic acid, and synthetic ammonia, with a focus on companies like Batian Co., Ltd. and others in the phosphate sector [7][9] Price Trends - As of April 3, 2025, the price of phosphate rock was 1,038 CNY/ton, with slight fluctuations in related fertilizer prices [19] - The Brent and WTI crude oil prices were reported at 66.06 and 62.32 USD/barrel, respectively, indicating a week-on-week decrease of approximately 9.98% and 9.73% [12]

Core Viewpoint - Lianhua Technology's stock closed at 7.04 yuan on April 1, with a market capitalization of 6.416 billion yuan, reflecting a net inflow of 410,000 yuan in main funds on the same day, although it has seen a total outflow of 7.0118 million yuan over the past five days [1] Company Overview - Lianhua Technology Co., Ltd. specializes in fine chemicals and equipment and engineering services, with key segments including crop protection raw materials, pharmaceuticals, and functional chemicals [1] - The company has established itself as a strategic supplier for major international agricultural and pharmaceutical companies, being recognized as a key high-tech enterprise under the National Torch Program [1] Financial Performance - For the third quarter of 2024, Lianhua Technology reported revenue of 4.359 billion yuan, a year-on-year decrease of 13.14%, while net profit reached 32.5038 million yuan, showing a significant increase of 143.13% [1] - The company's gross profit margin stands at 22.71% [1] Valuation Metrics - Lianhua Technology has a price-to-earnings (PE) ratio of -17.95 (TTM) and a price-to-book (PB) ratio of 1.01, with a total market value of 6.416 billion yuan [2] - The industry average PE is 47.12, while the industry median PE is 33.32, indicating that Lianhua Technology's valuation metrics are significantly lower than the industry averages [2]

Company Overview - Jiangsu Zhongqi Technology Co., Ltd. specializes in the research, production, and sales of pesticide products, primarily focusing on herbicides and insecticides [1][2] - The company has become a strategic supplier for multinational agrochemical companies such as Corteva (Dow DuPont), Bayer, Syngenta, and BASF [1] Financial Performance - For the third quarter of 2024, the company reported a revenue of 1.779 billion yuan, a year-on-year decrease of 10.14% [2] - The net profit for the same period was 26.5176 million yuan, reflecting a significant year-on-year decline of 86.93% [2] - The sales gross margin stood at 15.59% [2] Market Position - As of the latest data, Zhongqi's rolling price-to-earnings (PE) ratio is 188.24, significantly higher than the industry average of 46.84 and the industry median of 33.12 [1][2] - The company's total market capitalization is 2.863 billion yuan [1] Industry Recognition - Zhongqi has received several accolades, including being listed among the top 500 enterprises in China's petroleum and chemical industry in 2022 and ranking 15th in the top 50 pesticide exporters in 2023 [1]

Investment Rating - The report does not explicitly provide an investment rating for the agricultural chemicals and veterinary drugs industry [1]. Core Insights - The agricultural chemicals industry is nearing the end of a "de-inventory" phase, with signs of order volume recovery observed in Q4 2024. The company plans to maintain its "major client strategy" while expanding its customer base and exploring new product directions [18]. - The pharmaceutical business is progressing as planned, with stable development expected. The company is focusing on deepening relationships with existing major clients and enhancing R&D capabilities [19]. - The renewable energy business is advancing, with plans to enter the market with products like electrolytes. The company aims for revenue breakthroughs in 2025 while optimizing technology and operational efficiency to remain competitive [20]. - The establishment of operations in the UK and Malaysia is intended to provide a stable supply chain and enhance service quality for clients, countering trends of industry chain relocation [20]. - The impact of U.S. tariff policies on the company's business is limited, as the share of products delivered to U.S. ports is small [20]. - The rise of Indian CDMO companies is acknowledged, but the company believes that its competitive edge in proprietary drugs remains intact due to concerns over supply chain integrity and IP protection in India [21]. Summary by Sections 1. Basic Research Information - The research focused on the company "Lianhua Technology" within the agricultural chemicals and veterinary drugs industry, conducted on March 12, 2025, with participation from various financial institutions [13]. 2. Detailed Research Institutions - The research involved institutions such as Kaiyuan Securities, Tianfeng Securities, Haitong Asset Management, and Industrial Bank [14]. 3. Research Institution Proportions - The report does not provide specific data on the proportions of research institutions involved [16]. 4. Main Content Information - The company is actively managing its inventory levels in the agricultural sector and is optimistic about future order volumes. It is also expanding its pharmaceutical and renewable energy businesses while maintaining a focus on major clients and operational efficiency [18][19][20].

特别提示： 1、本次股东大会无否决议案的情形。 证券代码：002250 证券简称：联化科技 公告编号：2024-048 联化科技股份有限公司 2024 年第二次临时股东大会决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记 载、误导性陈述或重大遗漏。 2、本次股东大会不涉及变更以往股东大会已通过的决议。 一、会议召开和出席情况 （一）会议召开情况 1、会议时间：2024年10月30日（星期三）15时00分 2、会议地点：浙江省台州市黄岩区劳动北路118号总商会大厦17楼会议室 3、会议召集人：联化科技股份有限公司董事会 4、会议方式：现场投票与网络投票相结合的方式 5、会议主持人：董事长王萍女士 6、会议的召集、召开与表决程序符合《公司法》《上市公司股东大会规则》《深 圳证券交易所股票上市规则》等法律、法规及规范性文件和《公司章程》的规定。 （二）会议出席情况 本次股东大会按照会议议程，以现场记名投票与网络投票表决方式审议通过了 如下决议： 1、审议通过《关于变更回购股份用途并注销的议案》，该项议案获得出席本次 股东大会有效表决权股份总数的2/3以上通过。 表决结果： | | 可参 ...

证券研究报告|公司动态点评 2024 年 09 月 03 日 联化科技（002250.SZ） 2Q24 业绩环比改善，关注公司中长期成长性与英国基地改善 | --- | --- | --- | --- | --- | --- | --- | --- | |--------------------------------------------|-------|--------|-------|-------|-------|-----------------------------------------|----------| | 财务指标 | 2022A | 2023A | 2024E | 2025E | 2026E | 买入（维持评级） | | | | | | | | | | | | 营业收入（百万元） | 7,865 | 6,442 | 6,317 | 7,858 | 9,472 | 股票信息 | | | 增长率 yoy （ % ） | 19.4 | -18.1 | -1.9 | 24.4 | 20.5 | | | | 归母净利润（百万元） | 697 | -465 | 86 | 351 | 614 ...

联化科技股份有限公司（以下简称"公司"）定于2024年5月8日（星期三） 15:00-17:00在全景网举办2023年度业绩说明会，本次年度业绩说明会将采用网络 远程的方式举行，投资者可登陆全景网"投资者关系互动平台"（https://ir.p5w.net） 参与本次年度业绩说明会或者直接进入公司路演厅 （https://ir.p5w.net/c/002250.shtml）参与本次年度业绩说明会。 出席本次说明会的人员有：公司董事长兼总裁王萍女士、高级副总裁兼董事 会秘书陈飞彪先生、财务总监薛云轩先生和独立董事俞寿云先生等。 为充分尊重投资者、提升交流的针对性，现就公司2023年度业绩说明会提前 向投资者公开征集问题，广泛听取投资者的意见和建议。投资者可于2024年5月7 日（星期二）15:00前访问https://ir.p5w.net/zj/，或扫描下方二维码，进入问题征 集专题页面。公司将在2023年度业绩说明会上，对投资者普遍关注的问题进行回 答。 证券代码：002250 证券简称：联化科技 公告编号：2024-032 联化科技股份有限公司 关于举行 2023 年度网上业绩说明会的公告 本公司及董事会全 ...

联化科技股份有限公司 独立董事2023年度述职报告 ——Zhang Yun 本人1976年9月出生，美国国籍，博士学位，已取得独立董事资格证书。现任乔 治华盛顿大学会计系终身会计副教授、上海华培科技股份有限公司外部董事、北京 猎豹移动科技有限公司独立董事、学大（厦门）教育科技集团股份有限公司独立董 事、联化科技独立董事。 2022年9月21日，公司召开的2022年第三次临时股东大会选举本人为公司第八届 董事会独立董事。 二、是否存在影响独立性的情况 作为公司的独立董事，经自查，本人符合《上市公司独立董事管理办法》《深 圳证券交易所上市公司自律监管指引第1号——主板上市公司规范运作》等相关法律 法规中对独立董事独立性的相关要求，不存在影响独立性的情况。 三、2023年度履职情况 作为联化科技股份有限公司（以下简称"公司"）的独立董事，本人严格按照 《关于在上市公司建立独立董事制度的指导意见》、《关于加强社会公众股股东权 益保护的若干规定》、《深圳证券交易所上市公司自律监管指引第1号——主板上市 公司规范运作》等法律法规和《公司章程》、《独立董事制度》和《专门委员会工 作细则》等规章制度的有关规定，勤勉、忠实、尽 ...